- Making Medicines Safer - The Need for an Independent Drug Safety Board - http://www.nejm.org/content/1998/0339/0025/1851.asp
From the New England Journal of Medicine. "Currently, after a drug is approved for marketing, we rely on a voluntary reporting system based on the assumption that a drug is safe... It is remarkable that at a time when the technology for collecting and analyzing large amounts of data is readily available, an independent, comprehensive, and systematic program of post-marketing drug surveillance does not exist."
- Public Health and Personal Freedom - http://www.hedweb.com/bgcharlton/healthfreed.html
Argues that more emphasis should be given to personal freedom over public health, using the example of alcohol.
- Health Care Report - http://mwhodges.home.att.net/healthcare.htm
This site, in data graphic form, shows U.S. live expectancy trends and health care spending compared to other nations, raising challenging questions today and looking forward.
- Health Insurance - http://health4her.com/library/concerns/health-insurance.cfm
Most primary care providers will have a network of colleagues they can recommend specialty services. Article says your health care needs are best met when your care is coordinated between your primary care provider and your specialists. From Health4her.com.
- Human Rights and the Aids Crisis: The Debate Over Resources - http://www.hrw.org/editorials/2000/aids-p1.htm
International human-rights standards can help point a useful direction while we prepare ourseleves to face a new public-health challenge that has come to the fore in the fight against AIDS.
- Not Another Generation Exposed To Asbestos - http://www.angelfire.com/al4/ban_asbestos/Not_Another_Generation_Exposed_To_Asbestos.html
An examination of asbestos, its effects on the human body, the state of mesothelioma treatments, and pending legislation on asbestos issues.
- The Bush Presidency - Bush Record on Health - http://www.theBushPresidency.org/Health.htm
Articles explore the Medicare bill and its drug plan, the imported drug controversy, stem cell research, and the Administration's policy for the uninsured.
|
